Transcriptional upregulation of breast cancer resistance protein by 17β-estradiol in ERα-positive MCF-7 breast cancer cells

Oncology

Volumn 71, Issue 5-6, 2007, Pages 446-455

  Zhang, Yuhua ^a   Zhou, Gengyin ^a   Wang, Huaiping ^b   Zhang, Xiaofang ^a   Wei, Fulan ^c   Cai, Yongping ^a   Yin, Deling ^d  

^a SHANDONG UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c SHANDONG UNIVERSITY   (China)

^d East Tennessee State University   (United States)

Author keywords

17 Estradiol; BCRP; Breast cancer; Gene regulation; Promoter

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; PLASMID DNA; TAMOXIFEN;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION INITIATION; UPREGULATION;

ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; HUMANS; NEOPLASM PROTEINS; RESPONSE ELEMENTS; UP-REGULATION;

EID: 35348846046     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108594     Document Type: Article

References (31)

1. Borst P, Elferink RO: Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002;71:537-592.
2. Kage K, Tsukahara S, Sugiyama T, Asada S, Ishikawa E, Tsurou T, Sugimoto Y: Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int J Cancer 2002;97:626-630.
3. Ozvegy C, Litman T, Szakacs G, Nagy Z, Bates S, Varadi A, Sarkadi B: Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem Biophys Res Commun 2001;285:111-117.
4. Xu J, Liu Y, Yang Y, Bates S, Zhang JT: Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J Biol Chem 2004;279:19781-19789.
5. Bailey-Dell KJ, Hassel B, Doyle LA, Ross DD: Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta 2001;1520:234-241.
6. Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, Schellens JH: Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 2001;61:3458-3464.
7. Jonker JW, Buitelaar M, Wagenaar E, Van Der Valk MA, Scheffer GL, Scheper RJ, Plosch T, Kuipers F, Elferink RP, Rosing H, Beijnen JH, Schinkel AH: The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci USA 2002;99:15649-15654.
8. Doyle LA, Ross DD: Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003;22:7340-7358.
9. van Herwaarden AE, Jonker JW, Wagenaar E, Brinkhuis RF, Schellens JHM, Beijnen JH, Schinkel AH: The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine. Cancer Res 2003;63:6447-6452.
10. Sinues B, Fanlo A, Bernal ML, Mayayo E, Bello S, Rubio E, Isla D: MDR-1 C3435T genetic polymorphism and tobacco-related lung cancer. Oncology 2003;64:183-185.
11. Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA: Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst 1999;91:429-433.
12. Volk EL, Farley KM, Wu Y, Li F, Robey RW, Schneider E: Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res 2002;62:5035-5040.
13. Maliepaard M, van Gastelen MA, de Jong LA, Pluim D, van Waardenburg RC, Ruevekamp-Helmers MC, Floot BG: Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res 1999;59:4559-4563.
14. Allen JD, Brinkhuis RF, Wijnholds J, Schinkel AH: The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res 1999;59:4237-4241.
15. Volk EL, Schneider E: Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res 2003;63:5538-5543.
16. Kawabata S, Oka M, Shiozawa K, Tsukamoto K, Nakatomi K, Soda H, Fukuda M, Ikegami Y, Sugahara K, Yamada Y, Kamihira S, Doyle LA, Ross DD, Kohno S: Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem Biophys Res Commun 2001;280:1216-1223.
17. Ee PL, Kamalakaran S, Tonetti D, He X, Ross DD, Beck WT: Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) Gene. Cancer Res 2004;64:1247-1251.
18. Imai Y, Ishikawa E, Asada S, Sugimoto Y: Estrogen-mediated post transcriptional downregulation of breast cancer resistance protein/ ABCG2. Cancer Res 2005;65:596-604.
19. Imai Y, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y: Estrone and 17β-estradiol reverse breast cancer resistance protein-mediated multidrug resistance. Jpn J Cancer Res 2002;93:231-235.
20. Imai Y, Asada S, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y: Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol Pharmacol 2003;64:610-618.
21. Wang HG, Zhou L, Gupta A, Vethanayagam RR, Zhang Y, Unadkat JD, Mao Q: Regulation of BCRP/ABCG2 expression by progesterone and 17β-estradiol in human placental BeWo cells. Am J Physiol Endocrinol Metab 2006;290:E798-E807.
22. Yasuda S, Itagaki S, Hirano T, Iseki K: Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation. Biosci Biotechnol Biochem 2005;69:1871-1876.
23. Ifergan I, Shafran A, Jansen G, Hooijberg JH, Scheffer GL, Assaraf YG: Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis. J Biol Chem 2004;279:25527-25534.
24. Robey RW, Medina-Perez WY, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz AM, Ross DD, Bates SE: Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. Clin Cancer Res 2001;7:145-152.
25. Chen ZS, Robey RW, Belinsky MG, Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE, Kruh GD: Transport of methotrexate, methotrexate polyglutamates, and 17β-estradiol 17-(β-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res 2003;63:4048-4054.
26. Xing W, Sairam MR: Characterization of regulatory elements of ovine follicle-stimulating hormone (FSH) receptor gene: the role of E-box in the regulation of ovine FSH receptor expression. Biol Reprod 2001;64:579-589.
27. Klinge CM: Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001;29:2905-2919.
28. Sanchez R, Nguyen D, Rocha W, White JH, Mader S: Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays 2002;24:244-254.
29. Dubik D, Shiu RP: Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 1992;7:1587-1594.
30. Weisz A, Rosales R: Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res 1990;18:5097-5106.
31. Sugimoto Y, Tsukahara S, Imai Y, Ueda K, Tsuruo T: Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists. Mol Cancer Ther 2003;2:105-112.